active
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey somebody has started buying on the rumor
Brace your selves it's gonna be one of those days.......
Looking for some fireworks this week!
GOOOOOOOOOOOOOOOOOOOOO SMTR!!!
Hope springs eternal!!!
That's your best post yet illwill!
Great stuff... thanks Grateful.
Everyone should listen to this broadcast:
http://65.77.20.28/SMTR/
That's a beautiful story.
Good morning ann441j.......
At that meeting one of the respected posters on RB posted that SMTR revealed that one of their customers is Qualcomm.... If that is true this baby is gonna move because they are the premier wireless communication co. in the world. I use to work in the transportaion industry and Qualcomm is the communication co. used on most of the HUGE truck fleets in this country. I hope we will hear more on this soon.
GOOOOOOOOOOOOOOOO SMTR!
Mistakes or false interpretations abound in many reports, we all remember this one..
Press Release Source: DNAPrint genomics, Inc.
DNAPrint genomics Shares Trading Without Interruption Following Erroneous Announcement by NASD of Deletion From Over-the-Counter Bulletin Board
Wednesday April 13, 8:04 am ET
http://biz.yahoo.com/prnews/050413/flw012.html?.v=7
So it is prudent to respond with some reservations until all the facts are in, don't you think?
I hope it's compensation for a BIG deal soon to be announced!!
Are sure it's a buy?... or gift?
http://www.pinksheets.com/quote/print_filings.jsp?url=%2Fredirect.asp%3Ffilename%3D0001144204%252D05....
I noticed that article also... good tie-in.
I stay in Atlanta.....
Great post Arch... the future is here.
Can you believe this post by yours truly...
http://ragingbull.lycos.com/mboard/boards.cgi?board=DNAP&read=337011
I am glad to learn that Gabriel and his wife must now finally produce or hit the road. I felt they should have been fired before the meeting. I personally feel it was an outrage for at least him not to attend the meeting as the CEO because of a death in his wife's family. After all, he has responsibility and accountability to hundreds of shareholders with millions of dollars invested under his leadership and he decides not to show up at this extremely important meeting? Guess he did not want to answer the hardball questions.Unbelievable and tragic.
JMHO
dr f
Thank you very much eb0783... have a good evening and we will seeya tomorrow.
I may not be speaking but I'm always reading
OT: ann441, I've OK just busy learning about this new computer and entertaining some life long friends visiting from Louisiana.
Great link ann441j... eom.
Amen Miss Scarlet, eom.
If I can get my hands on some more funds I'm buying.
Press Release Source: DNAPrint genomics
DNAPrint Launches Research to Enhance Law Enforcement Forensics Technology With 3D Biometric Capability
Friday June 10, 9:33 am ET
SARASOTA, Fla., June 10 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP - News; the "Company") today announced that it has begun research on developing 3D biometric applications for the Company's DNAWitness(TM) law enforcement forensics technology.
ADVERTISEMENT
"The ability to interpret whether DNA recovered at a crime scene can reveal anything about a person's likely facial features and other attributes of physical appearance would be a significant tool for forensic investigators and a valuable enhancement for our DNAWitness product," stated DNAPrint President and Chief Executive Officer Richard Gabriel.
The aim of the project is two-fold, according to Dr. Mark Shriver, Associate Professor of Biology Anthropology at Penn State University, where the research is being conducted. "We want to provide better tools for forensics professionals to infer physical appearance indirectly through assessment of BioGeographical (or genomic) Ancestry and to discover new genes that underlie specific phenotypes or physical features," he stated.
DNAPrint's anthropometric databases currently are built from and/or comprised of 2-dimensional digital photographs. One of the research project's goals is to integrate new 3D technology purchased by DNAPrint from Atlanta- based 3dMD ( http://www.3dmd.com ) with DNAWitness. The 3D application is also expected to enable anthropometric features to be documented with the precision required for sensitive and comprehensive genome research.
DNAPrint's DNAWitness technology for law enforcement analyzes DNA recovered from a crime scene. In August 2004 the Company introduced RETINOME(TM) for determining human iris (eye) color from DNA samples. DNAPrint also recently introduced a DNAWitness test kit that enables forensics experts to conduct their own tests in their own facilities without sending recovered DNA back to the Company for analysis.
DNAWitness forensics technology is the only testing method available with predictive capability that can identify the percentage of a person's genetic makeup among four possible groups -- Sub-Saharan African, Native American, East Asian and Indo-European plus the recent addition of Northern European, Middle Eastern, Mediterranean and Indo (Pakistan and India). This broadens an investigator's ability to provide a description of a person of interest. It is a valuable investigative tool for analyzing DNA recovered at a crime scene because it narrows the search for potential suspects, reducing cost and time in making an apprehension.
Dr. Shriver is conducting the research as part of a population genomic study at Penn State entitled "The Genetics of Human Pigmentation, Ancestry and Facial Features" and is utilizing the 3D technology in his laboratory to document anthropometric facial-cranial traits of research subjects. This information is valuable for forensic scientists in reconstructing physical characteristics from crime scene DNA, but is also useful for geneticists in designing studies aimed at identifying the underlying genes.
"Our common goal remains the same, to help investigators solve cases," Mr. Gabriel stated. "We have now participated in more than 80 law enforcement cases, eliminating speculation and changing the direction and focus of many investigations. Upon completion of beta testing some time this year on our new DNAWitness(TM) test kit, forensics experts in every crime laboratory in the world will have easy access to our technology."
DNAPrint has been at the forefront of the effort to optimize Admixture Mapping (AM) methodology using eye, hair and skin pigmentation (which are relatively easy to measure) as model systems. In the journal Genetics in 2003, DNAPrint scientists described one such gene called OCA2 as the primary human iris color gene, and Dr. Shriver has identified a number of genes that may be involved in skin pigmentation. Until now, the genetics of facial features has been very difficult to investigate as geneticists have been limited by older technologies that were not capable of precise objective anthropometric measurement.
About DNAPrint genomics, Inc.
DNAPrint genomics, Inc. ( http://www.dnaprint.com ) is a developer of genomic and pharmaceutical products and services focused on applications for new drugs, forensics technology for the law enforcement market and consumer products for individuals interested in learning their family heritage. DNAPrint products include ANCESTRYbyDNA(TM), EURO-DNA(TM) and DNAWitness(TM) and are available by contacting the company or visiting our web site. Other products in development include OVANOME(TM), a test for predicting a cancer patient's response to TAXOL/Carboplatin treatment; STATINOME(TM), a test for predicting the response to cholesterol lowering medicines known as Statins and "Super EPO" and the Company's first drug development project, an erythropoietin dimer used to treat kidney dialysis patients.
Forward-Looking Statements
All statements in this press release that are not historical are forward- looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
Company Contact:
Richard Gabriel
President and CEO
941-366-3400
-or-
Ron Stabiner
The Wall Street Group, Inc.
212-888-4848
Source: DNAPrint genomics
I'm not getting it frogdreaming.... what is it?
OT: My co buying out yours: http://www.thestreet.com/_yahoo/stocks/brokerages/10226632.html?cm_ven=YAHOO&cm_cat=FREE&cm_...
Thanks for posting that great web page ExtremeSport... finally a easy chart to follow>GOOOOOOOOOO DNAP!!
Thanks dkgross for posting that info... I particularly liked the last sentence in this paragraph.
"The implementation of the TREAD Act is providing major opportunities to grow our business," say Robert Rudman, SmarTire President and CEO. "In developing our tire pressure monitoring systems, additional growth opportunities are rapidly emerging in other transportation based wireless applications such as homeland security, vehicle and driver safety and asset management. By leveraging our extensive core industry experience and our patented wireless technologies, SmarTire is well positioned to capitalize on these emerging opportunities. In the meantime, the market for our current tire monitoring systems for cars, motorcycles, trucks, RVs, buses and industrial vehicles continues to grow and develop. We encourage all our shareholders and interested investors to listen to the webcast of the presentation."
Why the new alias dr?
Great post cosmiclifeform.... thanks a million!
I'm showing no trades on DNAP... whatsup?
Amen Miss Scarlet!
News out can't pull it up..
Patent news would be good about now!!!
Great news, thanks for sharing.... BTW-Where is that dealer located?
Amen Miss Scarlet.... Awomen